Substantial increases in the concentrations of the excitotoxin and N-methyl-D-aspartate-receptor agonist quinolinic acid (QUIN) 
INTRODUCTION
Quinolinic acid (QUIN) is a neurotoxic kynurenine-pathway metabolite derived from L-tryptophan, which mediates nerve-cell killing via activation of N-methyl-D-aspartate-type excitatory amino acid receptors [1, 2] . Substantial elevations of QUIN concentrations have been demonstrated in both cerebrospinal fluid and brain tissue of patients and non-human primates with a broad spectrum of infectious and other inflammatory neurologic diseases, including AIDS (Acquired Immune Deficiency Syndrome) [3, 4] , simian AIDS [5] [6] [7] , poliovirus infection of the spinal cord [8] , Lyme disease [9] and septicaemia [10] . The clinical relevance of these increases in QUIN are highlighted by the significant correlations between the cerebrospinal-fluid QUIN concentrations and objective measures of neuropsychological impairments in HIV (Human Immunodeficiency Virus)-1-infected patients [3, 4] . Further, the measured concentrations of QUIN (low micromolar) in cerebrospinal fluid of some patients exceeded concentrations reported to be neurotoxic to certain neurons in vitro by up to two orders of magnitude (100 nm [2, 11] ). The mechanisms responsible for increasing QUIN production are unclear, but increased activity of indoleamine 2,3-dioxygenase, the first enzyme of the kynurenine pathway, in inflammatory-cell infiltrates after interferon-y stimulation has been postulated [3, 12] . However, L-kynurenine is considered to be the end-product of kynurenine-pathway metabolism in most extrahepatic cells, whereas 3-hydroxyanthranilic acid is the endproduct in macrophages [13] . Furthermore, it has been reported that macrophages infected with HIV-1 do not synthesize QUIN [11] . The purpose of the present study was to determine whether human macrophages can synthesize QUIN from L-tryptophan and to investigate the effects of indoleamine 2,3-dioxygenase activation by interferon-y on QUIN production. 
Preparation of peripheral-blood macrophages
Peripheral-blood macrophages from human volunteers were obtained from Advanced Biotechnologies Inc. (Columbia, MD, U.S.A.). Macrophages were incubated in a 75 cm3 plastic culture flask at a density of 107 cells/flask in 20 ml of tissue-culture medium, consisting of RPMI-1640 supplemented with 10% heat-inactivated fetal-bovine serum, 2 mM-L-glutamine, 25 jug of gentamicin/ml, 100 units of penicillin/ml and 100 ,ug of streptomycin/ml. Cells were cultured with 50,M-L-[13C 61tryptophan
and either with or without interferon-y (1000, 100 or 10 units/ml) at 37°C in humidified air containing 5 Dunnett's t-test [16] . Regression analysis was done by the method of least squares. A P value of < 0.01 was considered statistically significant. 
DISCUSSION
These results unequivocally demonstrate that human macrophages can synthesize QUIN from L-tryptophan (Fig. 1) . The enhanced accumulation of ['3C6]QUIN after interferon-y administration (Table 1) is consistent with the induction of indoleamine 2,3-dioxygenase [1 3] . It is noteworthy that the concentrations of [13C6]QUIN achieved in the incubation medium after interferony stimulation actually exceeded those reported in the cerebrospinal fluid, brain tissue and blood of patients and macaques with inflammatory neurological diseases [3, [5] [6] [7] 9 ,101. Therefore, QUIN synthesis from macrophages that have infiltrated the central nervous system could account for the QUIN concentrations measured in the cerebrospinal fluid and brain tissue. Localized macrophage infiltrates are a common feature of many inflammatory neurological diseases [17] , and so it is likely that local tissue levels substantially exceed cerebrospinal-fluid concentrations and levels in non-infiltrated brain areas [8] . Indeed, after poliovirus infection of macaques, spinal-cord QUIN concentrations exceeded those in cerebrospinal fluid, blood and frontal cortex [8] . We have proposed that QUIN may be an important mediator of neuronal damage and degeneration in responsive brain regions in inflammatory neurological diseases. In this context it is noteworthy that the micromolar concentrations of QUIN achieved in the incubation medium of the present study exceeded the levels reported to be neurotoxic [2,111. We conclude that QUIN can be synthesized from L-tryptophan in macrophages, particularly when macrophages are stimulated with interferon-y. From the concentrations achieved in the incubation media, such cells are likely to be an important source of QUIN in patients with inflammatory neurological disease.
